ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 634,36
0,23%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sonnet BioTherapeutics Holdings Inc (SONN)

  7. Sonnet BioTherapeutics Holdings Inc (SONN) Actualités

SONN

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SONN
DateHeureSourceTitreSymboleSociété
28/05/202414h00GlobeNewswire Inc.Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual MeetingNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/05/202413h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
16/05/202422h16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
15/05/202422h06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/05/202422h26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
02/01/202422h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/12/202322h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/12/202323h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/10/202302h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
26/10/202315h00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/09/202322h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/09/202317h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/08/202314h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
21/08/202322h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/08/202322h20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/08/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/07/202322h30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/07/202318h10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202315h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202314h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202314h40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
29/06/202323h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
29/06/202323h27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/06/202320h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
31/05/202314h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
10/05/202313h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/02/202322h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
08/02/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/02/202323h30Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SONN

Dernières Valeurs Consultées

EU
LR
Legrand
EU
VK
Vallourec
EU
CAP
Capgemini
EU
BN
Danone
EU
SGO
Cie de SaintGobain
NYSE
DIS
Walt Disney
EU
ACA
Credit Agricole
COIN
BTCUSD
Bitcoin
EU
ORA
Orange
EU
PX4
SBF 120
EU
BNP
BNP Paribas
EU
AI
Air Liquide
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés